C4 Therapeutics, Inc. logo CCCC - C4 Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 10
HOLD 3
SELL 1
STRONG
SELL
0
| PRICE TARGET: $7.00 DETAILS
HIGH: $7.00
LOW: $7.00
MEDIAN: $7.00
CONSENSUS: $7.00
UPSIDE: 96.63%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Revenue
Revenue 6.2 11.0 11.2 6.5 7.2 5.2 15.4 12.0 3.0 3.3 11.1 2.7 3.8 2.9 6.8 13.8 7.7 20.1 8.5 9.8 7.4 8.3 8.4 9.7 6.8 8.2 5.4 3.9 3.9
Cost of Revenue 1.8 0 0 0 0 1.8 2.1 2.0 0 1.7 2.0 0 29.0 30.7 29.7 31.3 26.2 26.6 24.3 23.3 20.5 20.4 0 0 16.3 16.0 12.9 9.5 9.5
Gross Profit 4.4 11.0 11.2 6.5 7.2 3.4 13.3 10.0 3.0 1.6 9.1 2.7 (25.3) (27.8) (22.9) (17.5) (18.5) (6.5) (15.8) (13.5) (13.1) (12.2) 8.4 9.7 (9.5) (7.8) (7.6) (5.6) (5.6)
Operating Expenses
R&D Expenses 24.6 25.0 26.0 26.2 27.1 32.5 31.8 23.8 22.5 30.4 28.3 29.9 29.0 30.7 29.7 31.3 26.2 26.6 24.3 23.3 20.5 20.4 23.9 17.8 16.3 16.0 12.5 12.5 9.5
SG&A Expenses 7.5 9.2 8.9 8.8 9.3 10.4 11.8 9.7 10.3 8.6 10.5 10.3 10.9 10.5 9.6 9.9 12.8 8.8 8.5 8.6 7.4 6.7 2.9 2.8 2.8 2.7 2.1 2.1 1.8
Other Expenses 0 0 10.7 0 0 (1.8) (2.1) (2.0) 2.4 0 (2.0) 0 (29.0) (30.7) (29.7) (31.3) (26.2) (26.6) (24.3) (23.3) 0 (20.4) 0 0 (16.3) (16.0) 0 0 0
Operating Expenses 32.1 34.2 45.6 35.0 36.4 41.1 41.5 31.4 35.3 39.0 36.9 40.2 10.9 10.5 9.6 9.9 12.8 8.8 8.5 8.6 27.9 6.7 26.8 20.5 2.8 2.7 14.7 14.7 1.7
Operating Income
Operating Income (27.8) (23.1) (34.4) (28.5) (29.2) (37.7) (28.2) (21.4) (32.2) (37.4) (27.8) (37.6) (36.2) (38.3) (32.5) (27.4) (31.4) (15.3) (24.3) (22.1) (41.0) (18.9) (18.3) (10.9) (12.3) (10.5) (10.0) (7.5) (7.5)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0.2 0.6 0.6 0.6 0.6 0.5 0.5 0.5 0.5 0.5 0.5 0.8 0.6 0.1 0 0 0 0 0
Interest Income 0 2.8 2.2 2.5 2.8 3.3 3.6 3.7 3.9 3.0 2.6 2.2 2.1 1.7 1.1 0.5 0.3 0.1 0.1 0.1 0.1 0 0.1 0.0 0.3 0.4 0.6 0.5 0.5
Profitability
EBITDA (26.0) (22.7) (31.7) (27.9) (28.7) (32.7) (22.6) (15.7) (29.3) (32.8) (23.9) (34.9) (35.7) (37.8) (32.1) (26.9) (31.1) (14.9) (23.9) (21.7) (20.1) (18.5) (21.0) (10.4) (11.9) (10.1) (9.6) (7.1) (7.1)
EBIT (27.8) (23.1) (32.2) (28.5) (29.2) (34.4) (24.7) (17.7) (29.8) (34.5) (25.9) (35.3) (36.2) (38.3) (32.5) (27.4) (31.4) (15.3) (24.3) (22.1) (20.5) (18.9) (21.4) (10.8) (12.3) (10.5) (10.0) (7.5) (7.5)
Income Before Tax (25.1) (20.4) (32.2) (26.0) (26.3) (34.4) (24.7) (17.7) (28.4) (34.5) (26.0) (35.9) (34.8) (37.2) (32.0) (27.4) (31.6) (15.7) (24.7) (22.6) (21.0) (21.7) (22.0) (11.0) (11.7) (9.9) (9.4) (6.9) (6.9)
Income Tax Expense 0 0.1 0 0 0 0.1 0 0 0 0.3 1.0 0 0 0 0 0 0 0 0 0 0 0.1 (0.2) (0.2) 0.2 0.1 0.7 0.1 0.1
Net Income (25.1) (20.5) (32.2) (26.0) (26.3) (34.6) (24.7) (17.7) (28.4) (34.8) (27.0) (35.9) (34.8) (37.2) (32.0) (27.4) (31.6) (15.7) (24.7) (22.6) (21.0) (21.8) (21.8) (10.8) (11.9) (10.0) (10.1) (9.1) (9.1)
Per Share Data
EPS (Basic) -0.20 -0.18 -0.44 -0.37 -0.37 -0.49 -0.35 -0.26 -0.41 -0.68 -0.55 -0.73 -0.69 -0.74 -0.64 -0.56 -0.66 -0.32 -0.51 -0.51 -0.49 -0.53 -0.54 -0.26 -0.69 -0.58 -0.59 -6.76 -6.76
EPS (Diluted) -0.20 -0.18 -0.44 -0.37 -0.37 -0.49 -0.35 -0.26 -0.41 -0.68 -0.55 -0.73 -0.69 -0.74 -0.64 -0.56 -0.65 -0.32 -0.51 -0.51 -0.49 -0.53 -0.54 -0.26 -0.69 -0.58 -0.59 -6.76 -6.76
Shares Outstanding 126.1 116.8 72.6 71.0 70.8 70.6 69.6 68.8 68.4 51.2 49.2 49.1 49.0 49.0 48.9 48.8 48.6 48.5 48.5 43.9 43.1 40.8 40.8 40.8 17.2 17.2 17.2 17.2 1.3
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q1
Current Assets
Cash & Cash Equivalents 61.3 74.6 58.8 78.2 51.3 55.5 59.6 73.1 89.7 126.6 61.0 44.9 49.5 29.8 49.6 57.3 46.0 76.1 162.7 281.1 94.9 181.7 63.4 112.2 (90.5) 90.5 (36.3)
Short-Term Investments 174.4 173.9 133.1 136.4 163.8 189.4 196.0 191.0 168.5 127.1 155.6 222.4 220.8 246.4 264.1 250.5 245.2 233.2 239.3 184.8 218.6 190.0 136.0 103.9 181.1 0 72.6
Net Receivables 2.9 2.4 6.5 2.2 8.0 3.1 10.3 1.2 13.6 11.8 0.5 1.0 0.5 1.5 1.5 1.7 1.8 5.7 4.8 6.2 3.7 4.5 4.1 8.5 0 4.6 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 6.8 7.2 8.4 8.0 9.4 9.8 7.2 10.8 7.8 5.7 6.6 6.1 7.6 9.9 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Current Assets 245.4 258.1 206.9 224.7 232.5 257.8 273.2 276.0 279.6 271.2 223.7 274.4 278.5 287.6 325.5 318.4 302.9 325.7 412.3 477.6 322.0 381.0 208.9 227.9 90.5 96.8 36.3
Non-Current Assets
Property, Plant & Equipment 43.6 45.3 47.1 59.8 61.4 63.4 65.4 67.4 69.1 71.1 72.8 74.6 76.2 77.5 79.0 79.5 77.9 35.1 15.6 16.2 16.9 16.6 17.1 17.6 0 18.9 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 36.0 52.0 7.9 11.9 19.6 22.4 28.8 31.6 41.0 28.0 29.9 19.4 34.7 61.0 52.4 90.1 130.5 142.2 78.2 32.8 32.5 0 0 0 0 0 0
Other Non-Current Assets 3.9 3.7 3.7 0.2 6.0 6.1 8.7 6.1 8.7 6.2 6.7 6.6 6.6 4.8 4.6 4.6 4.2 3.8 1.9 1.9 2.6 2.6 3.1 2.6 (90.5) 2.6 (36.3)
Total Non-Current Assets 83.5 101.0 58.6 71.8 87.0 91.8 102.8 105.0 118.8 105.3 109.3 100.6 117.6 143.3 136.0 174.1 212.5 181.1 95.6 50.9 52.0 19.1 20.2 20.1 (90.5) 21.5 (36.3)
Total Assets 328.9 359.1 265.5 296.5 319.5 349.6 376.1 381.1 398.4 376.5 333.0 375.0 396.0 430.8 461.4 492.5 515.5 506.8 507.9 528.4 374.0 400.1 229.1 248.1 0 118.3 0
Current Liabilities
Account Payables 0.8 0.9 1.3 2.2 0.7 1.3 1.5 0.9 1.6 1.4 1.3 2.2 1.0 1.2 2.4 4.4 3.4 4.5 3.7 4.5 3.7 5.7 5.3 5.9 0 5.4 0
Short-Term Debt 6.5 6.4 0 0 0 0 0 0 0 0 0 10.3 2.3 2.3 2.2 0.8 0.8 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 10.1 12.5 17.1 22.6 21.6 18.7 20.8 36.6 35.1 15.5 8.4 14.0 14.9 16.6 18.1 22.2 31.3 31.8 32.3 28.7 26.6 27.6 23.9 22.2 0 20.7 0
Other Current Liabilities 5.6 13.3 7.9 7.0 5.1 9.3 7.1 7.6 4.8 9.4 8.1 5.7 3.3 9.9 6.5 5.0 2.2 5.5 3.6 2.9 2.3 4.2 2.9 2.8 0 3.3 0
Total Current Liabilities 27.2 33.0 35.9 44.5 40.8 45.2 43.3 54.2 55.0 42.8 30.3 48.2 39.4 44.5 45.3 46.1 47.0 51.2 48.7 44.2 37.7 43.9 40.0 35.1 0 33.6 0
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 8.6 9.2 9.1 10.4 10.2 10.8 10.6 10.4 10.2 10.1 9.9 9.7 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 262.0 0 0 111.0 0
Total Non-Current Liabilities 67.4 69.5 75.1 78.0 83.6 88.4 90.1 79.8 85.1 87.6 86.7 93.1 94.2 97.1 98.0 101.7 104.0 65.9 60.4 67.8 72.6 75.5 345.0 89.2 0 196.6 0
Total Liabilities 94.6 102.5 111.1 122.5 124.4 133.6 133.4 134.0 140.1 130.3 117.0 141.3 133.6 141.6 143.3 147.9 151.0 117.2 109.1 112.0 110.3 119.3 385.1 124.3 0 230.2 0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0
Retained Earnings (763.8) (738.7) (718.2) (686.0) (660.0) (633.7) (599.1) (574.5) (556.7) (528.4) (493.6) (466.6) (430.7) (395.9) (358.7) (326.7) (299.3) (267.7) (252.1) (227.4) (204.8) (183.8) (162.0) (140.2) 0 (117.5) 0
Accumulated Other Comprehensive Income (0.3) 0.1 0.1 (0.0) 0.0 0.1 0.5 (0.4) (0.4) (0.1) (0.9) (1.8) (2.5) (4.1) (5.4) (4.6) (3.6) (0.8) (0.2) (0.1) (0.1) 0.0 0.0 (0.0) (112.0) 0 (79.8)
Total Stockholders' Equity 234.2 256.6 154.4 174.1 195.1 216.0 242.7 247.1 258.3 246.1 216.0 233.7 262.5 289.2 318.2 344.6 364.5 389.6 398.8 416.4 263.7 280.8 (155.9) 123.8 (1.0) (112.0) 31.2
Total Liabilities & Equity 328.9 359.1 265.5 296.5 319.5 349.6 376.1 381.1 398.4 376.5 333.0 375.0 396.0 430.8 461.4 492.5 515.5 506.8 507.9 528.4 374.0 400.1 229.1 248.1 (1.0) 118.3 31.2
Debt Metrics
Total Debt 58.4 60.0 61.5 62.9 64.4 65.8 67.1 68.4 69.7 71.0 72.2 83.7 85.5 87.2 88.1 86.3 87.4 42.9 22.7 22.8 22.8 22.9 23.0 23.0 0 13.7 0
Net Debt (2.8) (14.6) 2.7 (15.2) 13.1 10.3 7.4 (4.7) (19.9) (55.6) 11.2 38.8 36.0 57.4 38.5 29.0 41.4 (33.2) (140.1) (258.4) (72.1) (158.8) (40.5) (89.2) 90.5 (76.8) 36.3
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Operating Activities
Net Income (25.1) (20.5) (32.2) (26.0) (26.3) (34.6) (24.7) (17.7) (28.4) (34.8) (27.0) (35.9) (34.8) (37.2) (32.0) (27.4) (31.6) (15.7) (24.7) (22.6) (21.0) (21.8) (21.8) (10.8) (11.9) (10.0) (10.1) (7.0) (7.0)
Depreciation & Amortization 1.8 0.4 0.5 2.1 0.5 0.5 0.4 0.4 0.4 1.7 0.4 0.5 0.5 0.5 1.9 0.4 0.3 0.8 0.3 0.4 0.8 0.4 0.4 0.4 0.4 0.7 0.4 0.7 0.7
Stock-Based Compensation 0 4.0 4.6 0 5.5 8.2 8.8 6.4 6.2 6.4 8.2 6.4 6.3 6.9 0 8.1 8.9 0 6.1 5.2 0 2.7 0.4 0.2 0.1 0 0.6 0.1 0.1
Change in Working Capital (8.3) (6.7) (16.0) 7.2 (13.8) 7.4 (9) 5.9 3.4 3.4 (13.5) 9.4 (6.2) (0.7) (4.2) (5.7) (6.2) (18.1) (1.2) (1.9) (8.9) (5.8) 2.9 (6.1) (5.6) (2.1) 0.8 42.3 42.3
Other Non-Cash Items 1.7 0.6 11.9 4.6 0.9 0.5 0.3 0.0 0.2 20.2 1.7 0.7 1.1 1.3 6.2 2.3 2.0 7.4 1.1 0.9 4.1 0.5 0.5 1.7 0.3 1.1 0.3 0.8 0.8
Operating Cash Flow (29.9) (22.1) (31.2) (12.1) (33.3) (17.9) (24.1) (5.0) (18.1) (24.0) (30.7) (19.0) (33.1) (29.1) (28.0) (22.2) (26.6) (25.7) (18.4) (18.0) (24.9) (21.5) (14.4) (14.6) (16.7) (10.3) (7.9) 36.9 36.9
Investing Activities
Capital Expenditure (0.1) (0.0) (0.4) (0.2) 0 0.0 0.0 (0.2) 0 (0.2) (0.6) (0.4) (0.6) (1.5) (3.3) (0.5) (0.2) (0.1) 0 (0.7) (0.4) (0.3) (0.3) 0.1 (0.2) 0.1 (0.1) (0.6) (0.6)
Acquisitions 0 0 0 0 0 0 0 0 0 (32.1) (58.3) 0 (54.1) 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0
Purchases of Investments (40.8) (133.1) (46.7) (21.7) (25.6) (40.8) (68.6) (67.2) (107.7) (37.9) (31.9) (48.6) (11.4) (56.3) (55.1) (31.9) (76.2) (145.4) (154.7) (61.3) (176.3) (157.9) (32.0) 0 0 (64.1) 0 0 0
Sales/Maturities of Investments 57.0 52.3 51.2 60.8 54.8 54.5 68.7 55.7 54.4 70.0 90.3 64.2 65.6 67.1 78.3 65.7 72.4 86.1 54.1 94.5 115.0 104 0 0 0 63.8 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 32.1 58.3 0 54.1 0 0 0 0 0 0 0 0 (0.0) 0.0 (103.9) 0 0 14.9 (7.4) (7.4)
Investing Cash Flow 16.2 (80.7) 4.1 38.9 29.1 13.7 0.2 (11.7) (53.4) 31.9 57.7 15.1 53.5 9.3 19.9 33.2 (4.0) (59.4) (100.6) 32.4 (61.7) (54.2) (32.3) (103.8) (0.2) (0.2) 14.8 (8.1) (8.1)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 (11) (0.8) (0.8) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased (0.2) (0.0) (0.0) 0 (0.2) 0 (0.1) 0 (0.1) 0 (0.0) 0 (0.1) 0 0 0 0 0 0 0 0 0.0 (0.1) (0.9) 0 0.0 (0.0) (0.0) (0.0)
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0.1 0.0 0.3 0 0.1 0.0 0.3 0 0.6 (0.0) 0.3 0.0 0.1 0.0 0.1 0.3 0.5 (0.3) 1.1 170.5 (0.0) (145.8) (6.4) 153.1 0.2 0 0 0.0 0.0
Financing Cash Flow 0.5 118.7 7.8 0 (0.0) 0.1 10.5 0.1 34.6 57.7 (10.8) (0.7) (0.7) 0.0 0.4 0.3 0.5 0.5 0.6 170.5 (0.2) 194.1 2.5 152.2 0.2 0.1 0.1 0.0 0.0
Cash Position
Net Change in Cash (13.3) 15.8 (19.3) 26.9 (4.2) (4.2) (13.5) (16.5) (36.9) 65.6 16.3 (4.6) 19.7 (19.8) (7.7) 11.3 (30.1) (86.6) (118.4) 184.9 (86.8) 118.3 (44.2) 33.8 (16.7) 90.5 7.0 28.8 28.8
Cash at Beginning 74.6 62.3 81.6 51.3 58.9 63.1 76.6 89.7 126.6 61.0 48.2 52.8 33.0 52.8 57.3 49.3 79.4 162.7 282.4 97.5 181.7 66.0 110.2 76.4 93.1 0 96.6 67.7 0
Cash at End 61.3 78.0 62.3 78.2 54.7 58.9 63.1 73.1 89.7 126.6 64.4 48.2 52.8 33.0 49.6 60.6 49.3 76.1 164.0 282.4 94.9 184.3 66.0 110.2 76.4 90.5 103.5 96.6 28.8
Free Cash Flow (30.0) (22.2) (31.6) (12.2) (33.3) (17.9) (24.1) (5.2) (18.1) (24.2) (31.3) (19.4) (33.7) (30.6) (31.3) (22.7) (26.8) (25.8) (18.4) (18.7) (25.4) (21.8) (14.7) (14.5) (16.9) (10.2) (8.0) 36.3 36.3
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Income Statement
Revenue 6.2 11.0 11.2 6.5 7.2 5.2 15.4 12.0 3.0 3.3 11.1 2.7 3.8 2.9 6.8 13.8 7.7 20.1 8.5 9.8 7.4 8.3 8.4 9.7 6.8 8.2 5.4 3.9 3.9
Gross Profit 4.4 11.0 11.2 6.5 7.2 3.4 13.3 10.0 3.0 1.6 9.1 2.7 (25.3) (27.8) (22.9) (17.5) (18.5) (6.5) (15.8) (13.5) (13.1) (12.2) 8.4 9.7 (9.5) (7.8) (7.6) (5.6) (5.6)
Operating Income (27.8) (23.1) (34.4) (28.5) (29.2) (37.7) (28.2) (21.4) (32.2) (37.4) (27.8) (37.6) (36.2) (38.3) (32.5) (27.4) (31.4) (15.3) (24.3) (22.1) (41.0) (18.9) (18.3) (10.9) (12.3) (10.5) (10.0) (7.5) (7.5)
Net Income (25.1) (20.5) (32.2) (26.0) (26.3) (34.6) (24.7) (17.7) (28.4) (34.8) (27.0) (35.9) (34.8) (37.2) (32.0) (27.4) (31.6) (15.7) (24.7) (22.6) (21.0) (21.8) (21.8) (10.8) (11.9) (10.0) (10.1) (9.1) (9.1)
EPS (Diluted) -0.20 -0.18 -0.44 -0.37 -0.37 -0.49 -0.35 -0.26 -0.41 -0.68 -0.55 -0.73 -0.69 -0.74 -0.64 -0.56 -0.65 -0.32 -0.51 -0.51 -0.49 -0.53 -0.54 -0.26 -0.69 -0.58 -0.59 -6.76 -6.76
Balance Sheet
Cash & Equivalents 61.3 74.6 58.8 78.2 51.3 55.5 59.6 73.1 89.7 126.6 61.0 44.9 49.5 29.8 49.6 57.3 46.0 76.1 162.7 281.1 94.9 181.7 63.4 112.2 (90.5) 90.5 (36.3)
Total Assets 328.9 359.1 265.5 296.5 319.5 349.6 376.1 381.1 398.4 376.5 333.0 375.0 396.0 430.8 461.4 492.5 515.5 506.8 507.9 528.4 374.0 400.1 229.1 248.1 0 118.3 0
Total Debt 58.4 60.0 61.5 62.9 64.4 65.8 67.1 68.4 69.7 71.0 72.2 83.7 85.5 87.2 88.1 86.3 87.4 42.9 22.7 22.8 22.8 22.9 23.0 23.0 0 13.7 0
Stockholders' Equity 234.2 256.6 154.4 174.1 195.1 216.0 242.7 247.1 258.3 246.1 216.0 233.7 262.5 289.2 318.2 344.6 364.5 389.6 398.8 416.4 263.7 280.8 (155.9) 123.8 (1.0) (112.0) 31.2
Cash Flow
Operating Cash Flow (29.9) (22.1) (31.2) (12.1) (33.3) (17.9) (24.1) (5.0) (18.1) (24.0) (30.7) (19.0) (33.1) (29.1) (28.0) (22.2) (26.6) (25.7) (18.4) (18.0) (24.9) (21.5) (14.4) (14.6) (16.7) (10.3) (7.9) 36.9 36.9
Capital Expenditure (0.1) (0.0) (0.4) (0.2) 0 0.0 0.0 (0.2) 0 (0.2) (0.6) (0.4) (0.6) (1.5) (3.3) (0.5) (0.2) (0.1) 0 (0.7) (0.4) (0.3) (0.3) 0.1 (0.2) 0.1 (0.1) (0.6) (0.6)
Free Cash Flow (30.0) (22.2) (31.6) (12.2) (33.3) (17.9) (24.1) (5.2) (18.1) (24.2) (31.3) (19.4) (33.7) (30.6) (31.3) (22.7) (26.8) (25.8) (18.4) (18.7) (25.4) (21.8) (14.7) (14.5) (16.9) (10.2) (8.0) 36.3 36.3